Lakwa ke baad patients ke balance & chal (gait) par exercise ke sath sath dawa (fluoxetine) awam device (tDCS) ka prabhav

Effect of Dual-Task Exercise in Conjunction with Fluoxetine & Transcranial Direct Current Stimulation (tDCS) on Postural Stability and Gait in Stroke Patients.

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/05/008668

Enrollment

240

Registered

2017-05-25

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Stroke, Post stroke Impairment of Postural Satbility & Gait

Interventions

Intervention1: Fluoxetine: 20 mg Fluxetine for 45 days Intervention2: Group A: tDCS, Fluoxetine, DTT: Subjects in this arm will undergo 6 times a week for 2 weeks (12sessions) of bihemispheric active

Eligibility

Inclusion criteria

Inclusion criteria: 1. First-time ischemic or hemorrhagic stroke as diagnosed by CT/MRI 2. Ischemic or hemorrhagic stroke between 1 to 6 months from the index event that has caused hemiparesis, as examined and/or confirmed by medical records. 3. Able to stand with support 4. Both gender; age >= 18 years and 5. Conscious and comprehensible 6. Subjects need to be able to provide informed consent.

Exclusion criteria

Exclusion criteria: 1. Stroke patients 75 years 2. Patient with any disability other than stroke that would preclude gait training, 3. Taking antidepressant drugs two weeks before inclusion 4. Patients taking any other selective serotonin reuptake inhibitors (SSRI) at the time of enrollment or two weeks before inclusion. Patients taking any other medication likely to have adverse interaction with SSRIs Flaccid hemiplegia 8. Taking neuroleptic drugs or benzodiazepines 2 weeks before inclusion 9. Other major diseases with life expectancy 10. Any uncontrolled health condition for which exercise is contraindicated, 11. Any neurologic or orthopedic diseases that might interfere with the study, 12. Metallic implant within the brain 13. Epilepsy 14. Cardiac pace maker 15. Cognitive impairments 16. Pregnancy

Design outcomes

Primary

Measure	Time frame
Gait Analysis variables and FMA-LETimepoint: At Baseline, After 6 Weeks, and After 12 Weeks	—

Secondary

Measure	Time frame
1.NIHSS 2.Modified Rankin scale (mRS) 3. Modified Ashworth Scale (MAS) 4. Berg Balance Scale (BBS) 5. Time Up and Go Test (TUG) 6. Functional Reach Test (FRT) 7. Modified Barthel Index (mBI) Timepoint: At baseline, After 6 Weeks, And After 12 Weeks	—

Countries

India

Contacts

Public ContactB Roy

AIIMS, New Delhi

vasanthapadma123@gmail.com26594794

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026